Rob van Dalen

920 total citations
17 papers, 535 citations indexed

About

Rob van Dalen is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Rob van Dalen has authored 17 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Rob van Dalen's work include Antimicrobial Resistance in Staphylococcus (7 papers), Biochemical and Structural Characterization (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Rob van Dalen is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Biochemical and Structural Characterization (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Rob van Dalen collaborates with scholars based in Netherlands, Germany and Canada. Rob van Dalen's co-authors include Nina M. van Sorge, Andreas Peschel, Christoph Rademacher, Felix F. Fuchsberger, Jos A. G. van Strijp, Stephen E. Girardin, Dana J. Philpott, Elisabeth G. Foerster, Jessica Tsalikis and John R. Rohde and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Rob van Dalen

16 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rob van Dalen Netherlands 9 244 205 122 74 49 17 535
Timothy J. LaRocca United States 14 334 1.4× 169 0.8× 108 0.9× 110 1.5× 92 1.9× 24 709
Ryan G. Gaudet Canada 10 185 0.8× 233 1.1× 132 1.1× 96 1.3× 46 0.9× 11 564
Jonas Löfling Sweden 11 264 1.1× 88 0.4× 80 0.7× 112 1.5× 49 1.0× 11 485
Quanming Zou China 12 194 0.8× 81 0.4× 68 0.6× 144 1.9× 29 0.6× 37 470
Louis de Léséleuc Canada 9 208 0.9× 149 0.7× 159 1.3× 155 2.1× 28 0.6× 13 582
Hameem I. Kawsar United States 10 264 1.1× 141 0.7× 126 1.0× 59 0.8× 149 3.0× 26 600
Maria Georgieva United States 12 168 0.7× 112 0.5× 198 1.6× 175 2.4× 62 1.3× 17 480
Mary Speir Australia 13 408 1.7× 295 1.4× 79 0.6× 111 1.5× 84 1.7× 15 708
Komal Gurnani Canada 14 196 0.8× 264 1.3× 68 0.6× 49 0.7× 20 0.4× 21 493
Dennis J. Horvath United States 12 258 1.1× 195 1.0× 40 0.3× 130 1.8× 28 0.6× 21 638

Countries citing papers authored by Rob van Dalen

Since Specialization
Citations

This map shows the geographic impact of Rob van Dalen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob van Dalen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob van Dalen more than expected).

Fields of papers citing papers by Rob van Dalen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob van Dalen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob van Dalen. The network helps show where Rob van Dalen may publish in the future.

Co-authorship network of co-authors of Rob van Dalen

This figure shows the co-authorship network connecting the top 25 collaborators of Rob van Dalen. A scholar is included among the top collaborators of Rob van Dalen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob van Dalen. Rob van Dalen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dalen, Rob van, Maartje Ruyken, Carla J. C. de Haas, et al.. (2025). Antibody dependent complement activation is critical for boosting opsonophagocytosis of Staphylococcus epidermidis in an extremely preterm human whole blood model. Scientific Reports. 15(1). 31243–31243.
2.
Dalen, Rob van, Christoph Slavetinsky, Daniela S. Krause, et al.. (2024). The Capsular Polysaccharide Obstructs Wall Teichoic Acid Functions in Staphylococcus aureus. The Journal of Infectious Diseases. 230(5). 1253–1261. 5 indexed citations
3.
Dalen, Rob van, et al.. (2024). The two-component system ArlRS is essential for wall teichoic acid glycoswitching in Staphylococcus aureus. mBio. 16(1). e0266824–e0266824. 3 indexed citations
4.
Dalen, Rob van, et al.. (2023). Secretory IgA impacts the microbiota density in the human nose. Microbiome. 11(1). 233–233. 7 indexed citations
5.
Slavetinsky, Christoph, Rob van Dalen, Dorothee Kretschmer, et al.. (2023). Wall Teichoic Acid Mediates Staphylococcus aureus Binding to Endothelial Cells via the Scavenger Receptor LOX-1. ACS Infectious Diseases. 9(11). 2133–2140. 7 indexed citations
6.
Dalen, Rob van, Sara Ali, David Gerlach, et al.. (2021). Impact of Glycan Linkage to Staphylococcus aureus Wall Teichoic Acid on Langerin Recognition and Langerhans Cell Activation. ACS Infectious Diseases. 7(3). 624–635. 26 indexed citations
7.
Ali, Sara, Rob van Dalen, Nico J. Meeuwenoord, et al.. (2021). (Automated) Synthesis of Well‐defined Staphylococcus Aureus Wall Teichoic Acid Fragments. Chemistry - A European Journal. 27(40). 10461–10469. 9 indexed citations
8.
Dalen, Rob van, et al.. (2020). C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens. Frontiers in Cellular and Infection Microbiology. 10. 309–309. 79 indexed citations
9.
Dalen, Rob van, Andreas Peschel, & Nina M. van Sorge. (2020). Wall Teichoic Acid in Staphylococcus aureus Host Interaction. Trends in Microbiology. 28(12). 985–998. 98 indexed citations
10.
Dalen, Rob van, Felix F. Fuchsberger, Nienke H. van Teijlingen, et al.. (2019). Langerhans Cells Sense Staphylococcus aureus Wall Teichoic Acid through Langerin To Induce Inflammatory Responses. mBio. 10(3). 54 indexed citations
11.
Wamhoff, Eike‐Christian, Jessica Schulze, Felix F. Fuchsberger, et al.. (2019). A Specific, Glycomimetic Langerin Ligand for Human Langerhans Cell Targeting. ACS Central Science. 5(5). 808–820. 68 indexed citations
12.
Dalen, Rob van, Felix F. Fuchsberger, Christoph Rademacher, Jos A. G. van Strijp, & Nina M. van Sorge. (2019). A Common Genetic Variation in Langerin (CD207) Compromises Cellular Uptake of <b><i>Staphylococcus aureus</i></b>. Journal of Innate Immunity. 12(2). 191–200. 8 indexed citations
13.
Dalen, Rob van, David Gerlach, Guoqing Xia, et al.. (2019). The C‐type lectin receptor MGL sensesN‐acetylgalactosamine on the uniqueStaphylococcus aureusST395 wall teichoic acid. Cellular Microbiology. 21(10). e13072–e13072. 26 indexed citations
14.
Sorbara, Matthew T., Elisabeth G. Foerster, Jessica Tsalikis, et al.. (2018). Complement C3 Drives Autophagy-Dependent Restriction of Cyto-invasive Bacteria. Cell Host & Microbe. 23(5). 644–652.e5. 94 indexed citations
15.
Lopes, Fernando, Åsa V. Keita, José L. Reyes, et al.. (2018). ER-stress mobilization of death-associated protein kinase-1–dependent xenophagy counteracts mitochondria stress–induced epithelial barrier dysfunction. Journal of Biological Chemistry. 293(9). 3073–3087. 37 indexed citations
16.
Heijmen, Robin H., Cornelius Borst, Rob van Dalen, et al.. (1998). Temporary luminal arteriotomy seal: II. coronary artery bypass grafting on the beating heart. The Annals of Thoracic Surgery. 66(2). 471–476. 7 indexed citations
17.
Heijmen, Robin H., et al.. (1998). Temporary Luminal Arteriotomy Seal for Bypass Grafting. The Annals of Thoracic Surgery. 65(4). 1093–1099. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026